期刊文献+

sCAR-PPAb基因的原核表达载体构建及重组蛋白的表达纯化

Construction of Prokaryotic Expression Vector and Prokaryotic Expression,Purification of sCAR-PPAb
下载PDF
导出
摘要 为获得腺病毒受体sCAR与掌叶半夏蛋白(PPA)的亚基B(PPAb)的融合蛋白,将PPAb基因克隆入已构建的原核表达载体pQE30-sCAR中,经PCR和测序鉴定正确的重组质粒pQE30-sCAR-PPAb,转化大肠杆菌M15后获得工程菌。该菌株经IPTG诱导后,高效表达出带有组氨酸标签以包涵体形式存在的融合蛋白sCAR-PPAb。包涵体经过尿素变性溶解、PBS稀释复性、Ni离子亲和层析柱纯化,获得目的蛋白。SDS-PAGE及Western blotting分析表明,在42 kD左右有一条明显的特异性蛋白条带。同时细胞实验结果表明融合蛋白sCAR-PPAb能提高Ad-EGFP对Kasumi-1的感染效率。 To obtain a fusion protein containing soluble Coxsackie-adenovirus receptor (sCAR) and the domain B of Pinellia pedatisecta agglutinin (PPAb), the expression vector pQE30-sCAR-PPAb is con- structed by inserting domain B of PPA gene into pQE30-sCAR which has constructed and is identified by PCR and sequence analysis, Then an expression strain is selected after transformation of the recombined plasmid into E. coli M15, fusion protein with His-tag is efficiently expressed in the form of inclusion body after IPTG induction. The inclusion body is washed, dissolved in renatured by the gradual removal of urea via dialysis in solubilization buffer and purified by Ni^+2 chelate affinity chromatography under renatured condition. SDS-PAGE analysis and Western blotting with His-probe(mouse monoclonal IgG) show that the fusion protein with a molecular weight of about 42 is purified. Ad-EGFP transduction of leukemia cell lines Kasumi-1 is increased by sCAR-PPAb fusion protein, indicating that the purified protein is confirmed to be of bioactivity,
出处 《浙江理工大学学报(自然科学版)》 2010年第2期318-322,共5页 Journal of Zhejiang Sci-Tech University(Natural Sciences)
基金 国家自然科学基金(30801379 30800093) 浙江省生物医药工程重中之重学科开放基金(SWYX0804)
关键词 PPA sCAR-PPAb融合蛋白 亲和层析 PPA sCAR-PPAb fusion protein affinity chromatography
  • 相关文献

参考文献15

  • 1Hsu C C, Lin T W, Chang W W, et al. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids[J]. Gynecol Oncol, 2005, 96(2): 415-422.
  • 2Sawai H, Okada Y, Funahashi H, et al. Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells[J]. J Surg Res, 2008, 144(1): 117-123.
  • 3Guan Y, Gerhard B, Hogge DE. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)[J]. Blood, 2003, 101(8): 3142-3149.
  • 4Nangia-Makker P, Conklin J, Hogan V, et al. Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents[J]. Trends Mol Med, 2002, 8(4): 187-192.
  • 5Kuno A, Uchiyama N, Koseki-Kuno S, et al. Evanescent-field fluorescence-assisted lectin microarray~ a new strategy for glycan profiling[J]. Nat Methods, 2005, 2(11):851-856.
  • 6Welinder C, Jansson B, Ferno M, et al. Expression of helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes[J]. J Proteome Res, 2009, 8(2) : 782-787.
  • 7Chen Z, Kai G, Liu X, et al. cDNA cloning and characterization of a mannose-binding lectin from Zingiber offieinale Roscoe (ginger) rhizomes[J]. J Biosci, 2005, 30(2): 213 220.
  • 8Manning J C, Seyrek K, Kaltner H, et al. Glycomic profiling of developmental changes in bovine testis by lectin histochemistry and further analysis of the most prominent alteration on the level of the glycoproteome by lectin blotting and lectin affinity chromatography[J]. Histol Histopathol, 2004, 19(4) : 1043-1060.
  • 9Du X, Ho M, Pastan I. New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells[J]. J Immunother, 2007, 30(6): 607-613.
  • 10Pilobello K T, Mahal L K. Lectin microarrays for glycoprotein analysis[J]. Methods Mol Biol, 2007, 385: 193-203.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部